Brought to you by:
‘Endovation’: Guidelines from the front lines
Among the highlights from the “‘Endovation’—Endovascular Innovation for Urgent and Emergency Complex Aortic Disorders” session coming up at the 2022 Vascular Annual Meeting (VAM) Wednesday, June 15, is a presentation by Sukgu M. Han, MD, from the Keck Medical Center…
Cook Medical receives FDA Breakthrough Device designation for Zenith Thoraco+ endovascular system
Cook Medical’s Zenith Thoraco+ endovascular system (Thoraco+) has received Breakthrough Device designation from the Food and Drug Administration (FDA), a press release reports. The company details that, while the product is not commercially available yet, the benefits of the designation…
F/BEVAR review reveals less than 20% of patients suffered intraoperative adverse event
A retrospective evaluation of 600 fenestrated or branched endovascular aneurysm repairs (F/BEVARs) for the treatment of complex aneurysms revealed that fewer than one in five patients experienced an intraoperative adverse event, according to a press release announcing study results published…
The top 10 most popular Vascular Specialist stories in February
February’s top 10 includes a highlight from the 2022 Vascular and Endovascular Surgery Society (VESS) winter annual meeting and an interview with Melissa Kirkwood, MD, and colleagues at UT Southwestern in Dallas, Texas, regarding the lightweight shield designed to reduce…
Patients in Florida with complex aortic pathology gain unique access to F/BEVAR
This advertorial is sponsored by Tampa General Hospital. Patients with complex pararenal and thoracoabdominal aortic aneurysm (TAAA) disease are faced with limited treatment options outside of one of the most technically and physiologically demanding operations on a vascular surgeon’s schedule:…
Complex TAAA: US ARC IDE registry reports better survival vs. real-world data after endovascular repair
Patients treated in Food and Drug Administration (FDA)-approved investigational device exemption (IDE) trials for complex thoracoabdominal aortic aneurysms (TAAAs) in the U.S. Aortic Research Consortium (ARC) had better 30-day and one-year survival compared with those recorded in the real-world Vascular…
US IDE Aortic Research Consortium ‘pushes the envelope’ on F/BEVAR
The U.S. investigational device exemption (IDE) Aortic Research Consortium has produced the strongest data so far on the use of fenestrated/branched endovascular aneurysm repair (F/BEVAR), Andres Schanzer, MD, professor and chief of vascular surgery at the University of Massachusetts Medical School…
Hospital wins battle against time for one patient’s aortic emergency
This advertorial is sponsored by Tampa General Hospital. Aortic emergencies, if not diagnosed and managed in due time, are, of course, life threatening. Responding to them effectively requires the rapid activation of a complex health ecosystem. Even when these responses…
Clinical evaluation of robotic-assisted peripheral artery intervention in human completed
Aopeng Medical’s Allvas endovascular intervention surgical robot has successfully carried out a first-in-human clinical evaluation of a robot-assisted peripheral artery intervention of an iliac artery in the department of vascular surgery at Changhai Hospital in Shanghai, China. The procedure was…
Sanford invents Breakthrough Device for TAAA
An investigational device invented at Sanford Health in Sioux Falls, South Dakota, that helps high-risk vascular disease patients has been granted a Breakthrough Device designation by the Food and Drug Administration (FDA). Patrick Kelly, MD, a Sanford Health vascular surgeon,…